ReviewCurrent treatment options in gastroenterology2017
Endoscopic Evaluation and Management of Gastric Stromal Tumors.
Review in Current treatment options in gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Article
- A novel technique for endoscope progression in gastroscopy resection: forward-return way for dissection of stromal tumor in the muscularis propria of the gastric fundus.Frontiers in oncology · 2023Article
- Advancements in the Diagnosis of Gastric Subepithelial Tumors.Gut and liver · 2022Review
- Efficacy and feasibility of snare-assisted endoscopic resection of small submucosal gastric tumors: A retrospective analysis.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
opinion statementPurpose of Review Gastrointestinal stromal tumors (GISTs) are both relatively common. Management of these lesions has been challenging with emerging interest in the endoscopic approach for both diagnostic and therapeutic interventions. Recent Findings Although these can be visualized on CT scan, endoscopic ultrasound (EUS) represents the standard method of evaluation and characterization using fine needle aspiration cytology (FNA) when indicated. While EUS-FNA can yield diagnostic cells, full characterization requires a sufficient volume of viable cells to do molecular analysis for c-KIT and determine the mitotic index. A new generation of fine needle biopsy (FNB) needles holds promise for improving our ability to fully characterize these lesions which will hopefully lead to improved management. Very small GISTs (< 1 cm) can probably be ignored, those between 1 and 2 cm are often surveyed, and those > 2 cm should be resected if the patient is fit and the lesion is in an accessible location. Though laparoscopic wedge resection is considered the standard of care, for small GISTs, those that are endophytic and/or located in a difficult position, pure endoscopic or hybrid laparoscopic-endoscopic approaches offer promise. Summary This review highlights the emerging advanced endoscopic approaches to GISTs. Although endoscopic removal of GISTs has two major advantages-precise localization of the lesion and gastric preservation, best practice strategies should focus on available expertise of expert endoscopists.
Indexed as
Identifiers
29075963What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.